The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a public alert about a suspected ...
Roche's strategic acquisition of Poseida Pharmaceuticals positions them as a leader in the allogeneic cell therapy market.
Zacks.com on MSN9h
HALO Raises 2025 Financial Guidance, Keeps 2024 View, Stock UpShares of Halozyme Therapeutics, Inc. HALO were up 5% on Jan. 8 after the company raised its guidance for 2025. The stock gained another 1.8% in after-hours trading. HALO also maintained its full-year ...
The National Agency for Food and Drug Administration and Control (NAFDAC) warns the public against counterfeit cancer drugs Phesgo® 600mg ...
Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme" or the "Company") today provided a financial update, reiterating full ...
The National Agency for Food and Drug Administration and Control (NAFDAC) has notified Nigerians, including healthcare ...
NAFDAC has alerted healthcare providers and the public about a suspected counterfeit batch of Phesgo 600mg/600mg/10ml ...
The National Agency for Food and Drug Administration and Control (NAFDAC) has issued an urgent alert to healthcare providers ...
Daily Post Nigeria on MSN4d
NAFDAC alerts Nigerians on fake cancer treatment drugsThe National Agency for Food and Drug Administration and Control, NAFDAC, has alerted Nigerians, including healthcare ...
NAFDAC, has issued an alert to healthcare professionals and the public regarding a suspected counterfeit batch of drug.
The National Agency for Food and Drug Administration and Control (NAFDAC) has warned Nigerians to be wary of counterfeit cancer treatment drugs, Phesgo, in circulation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback